Bifidobacteria isolated from infants and cultured on human milk oligosaccharides affect intestinal epithelial function

Journal of Pediatric Gastroenterology and Nutrition

Volumn 55, Issue 3, 2012, Pages 321-327

  Chichlowski, MacIej ^a   De Lartigue, Guillaume ^a   Bruce German, J ^a   Raybould, Helen E ^a   Mills, David A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

bifidobacteria; inflammation; intestinal epithelial cells; milk oligosaccharides

Indexed keywords

BETA ACTIN; CYTOKINE; HUMAN MILK OLIGOSACCHARIDE; INTERLEUKIN 8; LACTOSE; MESSENGER RNA; OLIGOSACCHARIDE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL TRANSLOCATION; BACTERIUM ADHERENCE; BIFIDOBACTERIACEAE; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM LONGUM; BREAST MILK; CARBOHYDRATE METABOLISM; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; INFANT; INFLAMMATION; INTESTINE EPITHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIGHT JUNCTION;

BACTERIAL ADHESION; BIFIDOBACTERIUM; CACO-2 CELLS; CELL MEMBRANE; COLON; CULTURE MEDIA; HT29 CELLS; HUMANS; INTERLEUKIN-10; INTESTINAL MUCOSA; JUNCTIONAL ADHESION MOLECULES; MEMBRANE GLYCOPROTEINS; MILK, HUMAN; OCCLUDIN; OLIGOSACCHARIDES;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM LONGUM;

EID: 84865733463     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e31824fb899     Document Type: Article

References (70)

1. James DC, Lessen R. Position of the American Dietetic Association: promoting and supporting breastfeeding. J Am Diet Assoc 2009;109: 1926-42.
2. Nakamura N, Gaskins HR, Collier CT, et al. Molecular ecological analysis of fecal bacterial populations from term infants fed formula supplemented with selected blends of prebiotics. Appl Environ Microbiol 2009;75:1121-8.
3. German JB, Freeman SL, Lebrilla CB, et al. Human milk oligosaccharides: evolution, structures and bioselectivity as substrates for intestinal bacteria. Nestle Nutr Workshop Ser Pediatr Program 2008;62:205-18.
4. Kunz C, Rudloff S, Baier W, et al. Oligosaccharides in human milk: structural, functional, and metabolic aspects. Ann Rev Nutr 2000; 20:699-722.
5. Chichlowski M, German JB, Lebrilla CB, et al. The influence of milk oligosaccharides on microbiota of infants: opportunities for formulas. Annu Rev Food Sci Technol 2011;2:331-51.
6. Niñonuevo MR, Lebrilla CB. Mass spectrometric methods for analysis of oligosaccharides in human milk. Nutr Rev 2009;67:S216-26.
7. LoCascio RG, Ninonuevo M, Kronewitter S, et al. A versatile and scalable strategy for glycoprofiling bifidobacterial consumption of human milk oligosaccharides. Microb Biotechnol 2009;2:333-42.
8. LoCascio RG, Ninonuevo MR, Freeman SL, et al. Glycoprofiling of bifidobacterial consumption of human milk oligosaccharides demonstrates strain specific, preferential consumption of small chain glycans secreted in early human lactation. J Agric Food Chem 2007;55:8914-9. (Pubitemid 350105536)
9. Ward RE, Ninonuevo M, Mills DA, et al. In vitro fermentation of breast milk oligosaccharides by Bifidobacterium infantis and Lactobacillus gasseri. Appl Environ Microbiol 2006;72:4497-9. (Pubitemid 43894931)
10. Ward RE, Niñonuevo M, Mills DA, et al. In vitro fermentability of human milk oligosaccharides by several strains of bifidobacteria. Mol Nutr Food Res 2007;51:1398-405. (Pubitemid 350195613)
11. Sela DA, Chapman J, Adeuya A, et al. The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome. Proc Natl Acad Sci USA 2008;105:18964-9.
12. Sela DA, Li Y, Lerno L, et al. An Infant-associated bacterial commensal utilizes breast milk sialyloligosaccharides. J Biol Chem 2011;286: 11909-18.
13. Garrido D, Kim JH, German JB, et al. Oligosaccharide binding proteins from Bifidobacterium longum subsp. infantis reveal a preference for host glycans. PLoS ONE 2011;6:e17315.
14. LoCascio RG, Desai P, Sela DA, et al. Broad conservation of milk utilization genes in Bifidobacterium longum subsp. infantis as revealed by comparative genomic hybridization. Appl Environ Microbiol 2010; 76:7373-81.
15. Zivkovic AM, German JB, Lebrilla CB, et al. Human milk glycobiome and its impact on the infant gastrointestinal microbiota. Proc Natl Acad Sci USA 2011;108(suppl 1):4653-8.
16. Erickson AK, Willgohs JA, McFarland SY, et al. Identification of two porcine brush border glycoproteins that bind the K88ac adhesin of Escherichia coli and correlation of these glycoproteins with the adhesive phenotype. Infect Immun 1992;60:983-8.
17. Tuomola E, Crittenden R, Playne M, et al. Quality assurance criteria for probiotic bacteria. Am J Clin Nutr 2001;73:393S-8S. (Pubitemid 32113261)
18. Schiffrin E, Brassart D, Servin A, et al. Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection. Am J Clin Nutr 1997;66:515S-520. (Pubitemid 27360357)
19. He F, Ouwehand AC, Isolauri E, et al. Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunol Med Microbiol 2001;30:43-7. (Pubitemid 32145003)
20. Resta-Lenert S, Barrett KE. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 2003;52:988-97. (Pubitemid 36765291)
21. Bernet MF, Brassart D, Neeser JR, et al. Adhesion of human bifidobacterial strains to cultured human intestinal epithelial cells and inhibition of enteropathogen-cell interactions. Appl Environ Microbiol 1993;59:4121-8. (Pubitemid 23361396)
22. Crociani J, Grill JP, Huppert M. Adhesion of different bifidobacteria strains to human enterocyte-like Caco-2 cells and comparison with in vivo study. Lett Appl Microbiol 1995;21:146-8.
23. Candela M, Seibold G, Vitali B, et al. Real-time PCR quantification of bacterial adhesion to Caco-2 cells: competition between bifidobacteria and enteropathogens. Res Microbiol 2005;156:887-95. (Pubitemid 41405804)
24. Moroni O, Kheadr E, Boutin Y, et al. Inactivation of adhesion and invasion of food-borne Listeria monocytogenes by bacteriocinproducing Bifidobacterium strains of human origin. Appl Environ Microbiol 2006;72:6894-901. (Pubitemid 44748398)
25. Chichlowski M, Hale LP. Bacterial-mucosal interactions in inflammatory bowel disease-an alliance gone bad. Am J Physiol Gastrointest Liver Physiol 2008;295:G1139-4.
26. Ciccocioppo R, Finamore A, Ara C, et al. Altered expression, localization, and phosphorylation of epithelial junctional proteins in celiac disease. Am J Clin Pathol 2006;125:502-11.
27. Coeffier M, Gloro R, Boukhettala N, et al. Increased proteasomemediated degradation of occludin in irritable bowel syndrome. Am J Gastroenterol 2010;105:1181-8.
28. Gassler N, Rohr C, Schneider A, et al. Inflammatory bowel disease is associated with changes of enterocytic junctions. Am J Physiol Gastrointest Liver Physiol 2001;281:G216-28.
29. Zeissig S, Bürgel N, Günzel D, et al. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 2007;56:61-72. (Pubitemid 46044890)
30. Khailova L, Dvorak K, Arganbright KM, et al. Bifidobacterium bifidum improves intestinal integrity in a rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2009;297:G940-949.
31. Ewaschuk JB, Diaz H, Meddings L, et al. Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am J Physiol Gastrointest Liver Physiol 2008;295:G1025-34.
32. Turner JR. Molecular basis of epithelial barrier regulation: from basic mechanisms to clinical application. Am J Pathol 2006;169:1901-9. (Pubitemid 351181952)
33. Zyrek AA, Cichon C, Helms S, et al. Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta; redistribution resulting in tight junction and epithelial barrier repair. Cell Microbiol 2007;9:804-16. (Pubitemid 46231983)
34. Seth A, Yan F, Polk DB, et al. Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC-and MAP kinase-dependent mechanism. Am J Physiol Gastrointest Liver Physiol 2008;294:G1060-1069. (Pubitemid 351520059)
35. Resta-Lenert S, Barrett KE. Probiotics and commensals reverse TNF-[alpha]-and IFN-[gamma]-induced dysfunction in human intestinal epithelial cells. Gastroenterology 2006;130:731-46. (Pubitemid 43374524)
36. Preising J, Philippe D, Gleinser M, et al. Selection of bifidobacteria based on adhesion and anti-inflammatory capacity in vitro for amelioration of murine colitis. Appl Environ Microbiol 2010;76:3048-51.
37. Tanabe S, Kinuta Y, Saito Y. Bifidobacterium infantis suppresses proinflammatory interleukin-17 production in murine splenocytes and dextran sodium sulfate-induced intestinal inflammation. Int J Mol Med 2008;22:181-5.
38. Sheil B, MacSharry J, O'Callaghan L, et al. Role of interleukin (IL-10) in probiotic-mediated immune modulation: an assessment in wild-type and IL-10 knock-out mice. Clin Exp Immunol 2006;144:273-80.
39. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature 2000;406:782-7.
40. Bruewer M, Luegering A, Kucharzik T, et al. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol 2003;171:6164-72. (Pubitemid 37467239)
41. Faust D, Hormann S, Friedrich-Sander M, et al. Butyrate and the cytokine-induced (1-proteinase inhibitor release in intestinal epithelial cells. Eur J Clin Invest 2001;31:1060-3.
42. Bode L, Rudloff S, Kunz C, et al. Human milk oligosaccharides reduce platelet-neutrophil complex formation leading to a decrease in neutrophil ß 2 integrin expression. J Leukoc Biol 2004;76:820-6. (Pubitemid 39313718)
43. LoCascio RG. Glycomic and Genetic Characterization of the Metabolism of Human Milk Oligosaccharides by Bifidobacterium Species: Microbiology. Davis: University of California, Davis; 2009:241.
44. Barrangou R, Altermann E, Hutkins R, et al. Functional and comparative genomic analyses of an operon involved in fructooligosaccharide utilization by Lactobacillus acidophilus. Proc Natl Acad Sci USA 2003;100:8957-62. (Pubitemid 36899205)
45. Gnoth MJ, Rudloff S, Kunz C, et al. Investigations of the in vitro transport of human milk oligosaccharides by a caco-2 monolayer using a novel high performance liquid chromatography-mass spectrometry technique. J Biol Chem 2001;276:34363-70.
46. Pinto M, Robine-Leon S, Appay MD, et al. Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol Cell 1983;47:323-30. (Pubitemid 14236699)
47. Cencic A, Langerholc T. Functional cell models of the gut and their applications in food microbiology-A review. Int J Food Microbiol 2010;141:S4-14.
48. Jovani M, Barbera R, Farre R, et al. Calcium, iron, and zinc uptake from digests of infant formulas by Caco-2 cells. J Agric Food Chem 2001;49:3480-5. (Pubitemid 32845088)
49. Gretchen JM, Michael LS, Raymond PG. Characterization of Caco-2 and HT29-MTX cocultures in an in vitro digestion/cell culture model used to predict iron bioavailability. J Nutr Biochem 2009;20:494-502.
50. Clark E, Hoare C, Tanianis-Hughes J, et al. Interferon gamma induces translocation of commensal Escherichia coli across gut epithelial cells via a lipid raft-mediated process. Gastroenterology 2005;128:1258-67. (Pubitemid 40712177)
51. Anderson JM, Van Itallie CM. Physiology and function of the tight junction. Cold Spring Harb Perspect Biol 2009;1:a002584.
52. Riedel CU, Foata F, Goldstein DR, et al. Interaction of bifidobacteria with Caco-2 cells-adhesion and impact on expression profiles. Int J Food Microbiol 2006;110:62-8. (Pubitemid 44037851)
53. Ogawa K, Ben RA, Pons S, et al. Volatile fatty acids, lactic acid, and pH in the stools of breast-fed and bottle-fed infants. J Pediatr Gastroenterol Nutr 1992;15:248-52.
54. Ninonuevo MR, Ward RE, LoCascio RG, et al. Methods for the quantitation of human milk oligosaccharides in bacterial fermentation by mass spectrometry. Anal Biochem 2007;361:15-23. (Pubitemid 46027005)
55. Katayama T, Sakuma A, Kimura T, et al. Molecular cloning and characterization of Bifidobacterium bifidum 1,2-{alpha}-L-fucosidase (AfcA), a novel inverting glycosidase (glycoside hydrolase family 95). J Bacteriol 2004;186:4885-93. (Pubitemid 38970815)
56. Zweibaum A, Pinto M, Chevalier G, et al. Enterocytic differentiation of a subpopulation of the human colon tumor cell line HT-29 selected for growth in sugar-free medium and its inhibition by glucose. J Cell Physiol 1985;122:21-9. (Pubitemid 15177223)
57. Boesten R, Schuren F, Willemsen L, et al. Bifidobacterium breve-HT-29 cell line interaction: modulation of TNF-( induced gene expression. Beneficial Microbes 2011;2:115-28.
58. Gagnon M, Kheadr EE, Le Blay G, et al. In vitro inhibition of Escherichia coli O157:H7 by bifidobacterial strains of human origin. Int J Food Microbiol 2004;92:69-78. (Pubitemid 38368053)
59. Perez PF, Minnaard Y, Disalvo EA, et al. Surface properties of bifidobacterial strains of human origin. Appl Environ Microbiol 1998;64:21-6. (Pubitemid 28040286)
60. Guglielmetti S, Tamagnini I, Mora D, et al. Implication of an outer surface lipoprotein in adhesion of Bifidobacterium bifidum to Caco-2 cells. Appl Environ Microbiol 2008;74:4695-702.
61. Haller D, Bode C, Hammes WP, et al. Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte cocultures. Gut 2000;47:79-87. (Pubitemid 30430415)
62. Parlesak A, Haller D, Brinz S, et al. Modulation of cytokine release by differentiated Caco-2 cells in a compartmentalized coculture model with mononuclear leucocytes and nonpathogenic bacteria. Scand J Immunol 2004;60:477-85. (Pubitemid 39487515)
63. Morita H, He F, Fuse T, et al. Adhesion of lactic acid bacteria to Caco-2 cells and their effect on cytokine secretion. Microbiol Immunol 2002;46:293-7. (Pubitemid 34456681)
64. O'Hara AM, O'Regan P, Fanning A, et al. Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius. Immunology 2006;118:202-15. (Pubitemid 43727425)
65. Pozo-Rubio T, Mujico JR, Marcos A, et al. Immunostimulatory effect of faecal Bifidobacterium species of breast-fed and formula-fed infants in a peripheral blood mononuclear cell/Caco-2 co-culture system. Br J Nutr 2011;106:1216-23.
66. Candela M, Perna F, Carnevali P, et al. Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production. Int J Food Microbiol 2008;125:286-92.
67. Li Q, Zhang Q, Wang M, et al. Interferon-[gamma] and tumor necrosis factor-[alpha] disrupt epithelial barrier function by altering lipid composition in membrane microdomains of tight junction. Clin Immunol 2008;126:67-80. (Pubitemid 350266450)
68. Quigley EMM. Therapies aimed at the gut microbiota and inflammation: antibiotics, prebiotics, probiotics, synbiotics, anti-inflammatory therapies. Gastroenterol Clin North Am 2011;40:207-22.
69. Grimoud J, Durand H, de Souza S, et al. In vitro screening of probiotics and synbiotics according to anti-inflammatory and anti-proliferative effects. Int J Food Microbiol 2010;144:42-50.
70. Roberfroid MB. Prebiotics and synbiotics: concepts and nutritional properties. Br J Nutr 1998;80:S197-202. (Pubitemid 28510687)